Big Pharma talks Payer and Patient Engagement at PSA 2016

On September 28-30th, during the course of our annual three-dayPharmaceutical Strategy Conference (PSA) conference, over 120 biopharma ’s top strategists gathered at the Marriott Marquis Hotel, in New York City, to partake in meaningful discussions on the industry’s latest trends in deal-making, innovation, R&D, commercial and reimbursement strategies. Most importantly, the group of HCPs and industry experts joined for an honest dialog on the current relationship between the pharma companies, payers and patients.The roaster of experts were representatives from companies including Pfizer, McKinsey& Company, Takeda Pharmaceuticals, Otsuka America Pharmaceuticals, GSK, Astellas, Merck, Purdue Pharma, Huron Consulting, PwC, Regeneron Pharmaceuticals and Aetna, just to name a few.Here were some of the important points on the best practices of audience engagement and building lasting relationships that were captured during the course of the event:What does value mean in today ’s environment?Listen carefully to your customers and sales professionals; Establish connectivity with your customers and people within your organization; Patients question your values every day. As a pharma expert, you need to communicate your values in such a way that they align with the values of the patients.When I get up early in the morning I think to myself, ‘What would the patients say if they in the same room with me?’ - Deborah Waterhouse, GSKHow much is the patient decidi...

Source: ePharma Summit - October 17, 2016 Category: Pharmaceuticals Tags: Big Pharma biopharma Biopharmaceutical drug pricing HCPs Illness patient care Pharma Companies Pharma Experts pharma strategy pharmaceutical strategy Pharmaceutical Strategy Conference PSA treatment Source Type: blogs